938 filings
Page 2 of 47
8-K
1uur4mb49qieu1kulj
17 Mar 20
Assertio Therapeutics Agrees to Merge with Zyla Life Sciences to Create Synergistic Portfolio of Neurology and Non-Opioid Pain Products
8:02am
425
9476 k8qisbsxruxop
17 Mar 20
Business combination disclosure
8:00am
SC TO-I
c9t7aw7 9504rh0akdz
11 Mar 20
Issuer tender offer statement
7:52am
8-K
hhsq6hd4a9ckz3sv
11 Mar 20
Assertio Therapeutics Announces Offer to Purchase
6:01am
8-K
r1hrxb68zh1z
9 Mar 20
Assertio Therapeutics Announces Fourth-Quarter and Full-Year 2019 Financial Results
4:09pm
8-K
ttnf4hto8k2z3klm8ul7
20 Feb 20
Unaudited Pro Forma Financial Statements
5:24pm
4
jk6mc ts8
19 Feb 20
Assertio Therapeutics / Heather L Mason ownership change
5:00pm
SC 13G/A
ybw8cxagpr3
14 Feb 20
Assertio Therapeutics, Inc
11:14am
SC 13G/A
x22qrs7ct
14 Feb 20
Beneficial ownership report (amended)
12:00am
8-K
ufzfcpuhqxl ie1lezt
13 Feb 20
Assertio Therapeutics Announces Closing of Sale of NUCYNTA® Franchise to Collegium Pharmaceutical for $375.0 Million
4:56pm
SC 13G
4i1fhbvcoh1c
13 Feb 20
Assertio Therapeutics, Inc
1:28pm
SC 13G/A
nawovbpp
13 Feb 20
Beneficial ownership report (amended)
12:00am
4
3pglxsdiaatdvo4
12 Feb 20
Assertio Therapeutics / Daniel A. Peisert ownership change
6:41pm
4
mshoc
12 Feb 20
Assertio Therapeutics / ARTHUR J HIGGINS ownership change
6:41pm
4
sb2vgc3cyzint
12 Feb 20
Assertio Therapeutics / Stan Bukofzer ownership change
6:40pm
SC 13G/A
btky8gr
12 Feb 20
Beneficial ownership report (amended)
11:13am
SC 13G/A
xsw9n qqjs1gczig3q
12 Feb 20
Assertio Therapeutics, Inc
10:26am
8-K
nil kc83n46g
7 Feb 20
Assertio Therapeutics Announces Sale of NUCYNTA® Franchise to Collegium Pharmaceutical for $375.0 Million
2:42pm
4
lx2q4e
6 Feb 20
Assertio Therapeutics / Daniel A. Peisert ownership change
5:49pm